ACMT Position Statement: Off-Label Prescribing during COVID-19 Pandemic

Andrew I. Stolbach, Maryann Mazer-Amirshahi, Ryan Marino, Lewis S. Nelson, Jeremy Sugarman

Research output: Contribution to journalArticlepeer-review

Original languageEnglish (US)
Pages (from-to)342-345
Number of pages4
JournalJournal of Medical Toxicology
Issue number3
StatePublished - Jul 1 2020


  • COVID-19
  • Compassionate use
  • Coronavirus
  • Emergency use authorization
  • Expanded access
  • Off-label prescribing

ASJC Scopus subject areas

  • Toxicology
  • Health, Toxicology and Mutagenesis

Cite this